Assessment & treatment of children and adolescents with eating disorders in Queensland

About this resource

The aim of this guideline is to assist staff within Queensland Health Child and Youth Mental Health Services (CYMHS), Departments of Emergency Medicine, inpatient mental health units and paediatric medical wards when assessing a child or adolescent with a possible eating disorder, and deciding the most appropriate placement, treatment and care for the child or adolescent where admission to hospital is required. This decision is based on a number of safety issues and will need to be made on a case by case basis.
This guideline is not designed to be a prescriptive model of care, as no single model would cater for the heterogeneity of presentations seen throughout the state. The guideline provides suggested principles and minimum standards to enhance safe service delivery and assist practitioners in their decision making.
It is recommended that this guideline is used to support the formulation of local protocols and work instructions regarding clinical admission options, management of medical risks, governance issues and communication pathways. It is recognised that there are variations in local resources, and each case should be assessed on an individual basis depending on risk.

Year2020

See also

Clinical Guidelines for Therapeutic Interventions for Eating Disorders (EDQ)

Current clinical guidelines for the treatment of eating disorders in Australia are aimed at treatments for medical and psychiatric care in line with the DSM-5 and International Classification of Diseases (ICD-10).

Read more

Caring for Someone with an Eating Disorder

Family, carers and support services play a crucial role in the care, support and recovery of people with eating disorders and this resource is designed to assist these people in contributing to an effective collaborative care approach.

Read more

Issue 64 | Members' Meeting and Peer Work Guide

NEDC e-Bulletin Editor's Note: It is strange to reflect on the 10th anniversary NEDC Members’ Meeting 2020, held only a month ago on February 27-28 in Melbourne, with the knowledge of the drastic changes made to society due to the COVID-19 pandemic.

Read more

Eating Disorders and GLP-1 RAs

Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.

Read more